Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Common Stock | Options Exercise | $992K | +10.3K | +12.56% | $96.29 | 92.3K | Sep 13, 2024 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$992K | -8.34K | -9.03% | $118.97 | 84K | Sep 13, 2024 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$56.9K | -478 | -0.57% | $118.97 | 83.5K | Sep 13, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -10.3K | -100% | $0.00 | 0 | Sep 13, 2024 | Common Stock | 10.3K | $96.29 | Direct | F1 |
Id | Content |
---|---|
F1 | The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock. |